Skip to main content
. 2019 Sep 4;8(9):49. doi: 10.1038/s41389-019-0159-6

Fig. 6. Cell cytotoxicity of SCC EPHA2 isogenic cells with chemo drugs and small molecular inhibition.

Fig. 6

BEAS2B EPHA2 isogenic cells were used to treat a Taxol, b cisplatin, c SU11274, and d rapamycin. Mutation G391R cells showed resistant to cisplatin inhibition but sensitive to MET inhibitor SU11274 and mTOR inhibitor Rapamycin. EV: empty vector